These findings suggest that the TKs5-FGD1 complex and CDC42 activation are essential for MT1-MMP-mediated matrix remodeling and cell invasion, highlighting their potential as therapeutic targets to limit tumor cell invasiveness and metastatic potential. The gene discussed is SH3PXD2A; the disease is neoplasm.